NCT04977050View on ClinicalTrials.gov

The Role of Frequent Point-of-care Molecular Workplace Surveillance for Miners

NACompletedINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

February 22, 2021

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
Covid19
Interventions
DIAGNOSTIC_TEST

Quidel quickvue antigen test for COVID-19

rapid antigen test on nasal swab specimen for COVID-19

Trial Locations (1)

87131

University of New Mexico, Albuquerque

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

lead

University of New Mexico

OTHER

NCT04977050 - The Role of Frequent Point-of-care Molecular Workplace Surveillance for Miners | Biotech Hunter | Biotech Hunter